Keller Enterprises, a family office with a big commitment to venture philanthropy, has invested in Adial Pharmaceuticals, a biotech group developing a therapeutic agent for the treatment of alcoholism. The investment is one of a number the Louisiana and Virginia-based family office has made in the impact-linked space over the last few years.
Subscribe
You will need a Premium+ Subscription to read this article.
Exclusive news, analysis and research on global family enterprise and private investment offices
Already have an account? Sign in
Already have an account? Sign in
You've reached the end.
Continue reading free articles by registering as a Member.
Or choose a Premium Plan.
Already have an account? Sign in